According to Oxford University research, a tablet of a particular Vitamin B every day can lessen the rate of brain contraction in elder persons who are suffering from mild memory problems.
The biggest research for the effectiveness of B Vitamins on mild cognitive problem reaches two-year of irregular clinical trial, and one of the initial disease-amending trials in the field of Alzheimer’s disease to illustrate positive outcomes in people.
The statistic shows that one in six elder people that has an age of 70 up and has mild cognitive problem, experiencing difficulties with language, metal functions or memory, but not to a level that hinders with their daily lives.
An approximate half of individuals with mild cognitive problem go on to grow dementia, mostly Alzheimer’s disease, in five years of conclusion. The particular B Vitamins, Vitamin B12, Vitamin B6 and folic acid, are identified to manage the levels of amino acid homocysteine in the blood, and homocysteine’s high levels are connected with an increased risk of Alzheimer’s disease.
That is why the research team of Oxford University begins to see whether the B Vitamins’ supplements that lesser homocysteine can also slow down the superior rate of brain contraction or atrophy, observed in mild cognitive problem or Alzheimer’s disease.
Moreover, the research followed 168 people that have an age of 70 and up with mild memory impairments, half of them took high dosage of B vitamin tablets for the span of two years and the other half placebo tablet.
The researchers evaluated disease development in this group by utilizing MRI scans to measure the rate of brain atrophy over the two year time. Through this experiment the team found out that on average the brains of people taking Vitamin B6, Vitamin B12 and folic acid cure contracted at a rate of 0.76 percent per year, while those people in the placebo group had a mean rate of brain contraction of 1.08 percent.



Recent Comments